The results showed that after grouping BLCA patient overall survival (OS) based on the median value of gene expression, low NFAT2 expression was strongly associated with the better or improved OS, whereas NFAT1, NFAT3, NFAT4, and NFAT5 expression were not related to OS in BLCA patients (Figure 3). The gene discussed is NFATC4; the disease is bladder transitional cell carcinoma.